Home / KEEP BUT DO NOT DISPLAY (page 9)

KEEP BUT DO NOT DISPLAY

Lifestyle Interventions Result in Modest Improvements in Type 2 Diabetes

Lifestyle-based weight loss intervention trials achieve modest reductions in weight and glycated hemoglobin (HbA1c) levels, according to a meta-analysis. From six studies comparing lifestyle intervention with usual care, the researchers found the pooled effect on weight (5,795 patients) to be −3.33 kg, and −0.29% on HbA1c (5,784 patients), with both …

Read More »

Combo Drug Glyxambi Now Available – One Pill, One Co-pay

Combo Drug Glyxambi is a combination of empagliflozin and linagliptin in a tablet form for adults with type 2 diabetes. Both empagliflozin, an SGLT-2, and linagliptin, a DPP-4 inhibitor, are already on the market separately. Glyxambi’s main benefit is combining two different diabetes drugs into a single pill (in this …

Read More »

Diabetes, a Silent Threat to US Economy

Obesity is costly. Some of those costs are surprising ($2.5 billion wasted in gasoline). Others represent true injustice (obese black women earn 34% less than the rest of the workforce). But as significant as these diverse amounts are, they are almost incidental in comparison to the health care costs resulting …

Read More »

Cardiorespiratory Fitness Correlates with Glycemic Control

High HbA1c, high-fasting glucose and impaired oral glucose tolerance are related to lower cardiorespiratory fitness levels, according to recent findings. Cardiorespiratory fitness also appears to be associated with pancreatic beta-cell insulin secretory compensation for changing insulin sensitivity. “The association provides additional evidence highlighting the importance of fitness in protection against …

Read More »

Increased Diabetes Risk with Antibiotic Use

Taking at least two courses of prescribed antibiotics was associated with a higher risk of developing type 2 diabetes, according to a new study. The likelihood of getting diabetes increased by 8% after receiving two to five courses of penicillin. For patients who took two to five courses of quinolones, …

Read More »

Diabetes Patients Face Higher Health Cost and Reduced Life Span

A study in Diabetes Care found fewer life years and greater health care expenses linked to diabetes. For individuals with diabetes, the predicted life expectancy had an inverted U-shape for most BMI classifications, with overweight individuals having the highest life years lost. Higher lifelong health costs were seen in whites and …

Read More »

Curbing Atrial Fibrillation with Weight Loss in Obese People

Australian researchers found a higher odds of eliminating symptoms of atrial fibrillation in obese patients who lost at least 10% of their body weight without undergoing surgery or medication than in those who failed to lose weight. The findings were presented at the American College of Cardiology meeting. — Journal …

Read More »